Transcriptomics

Dataset Information

0

Optimized delivery of dual co-stimulation and anti-tumor activity using parallel chimeric antigen receptors (pCARs)


ABSTRACT: Second generation (2G) chimeric antigen receptors (CARs) contain a CD28 or 41BB co-stimulatory endodomain and elicit remarkable efficacy in hematological malignancies. Third generation (3G) CARs extend this linear blueprint by fusing both co-stimulatory units in series. However, clinical impact has been muted despite compelling evidence that co-signaling by CD28 and 41BB can powerfully amplify natural immune responses. We postulate that effective dual co-stimulation requires juxta-membrane positioning of endodomain components within separate synthetic receptors. Consequently, we designed parallel (p)CARs in which a 2G (CD28+CD3) CAR is co-expressed with a 41BB-containing chimeric co-stimulatory receptor. We demonstrate that the pCAR platform optimally harnesses synergistic and tumor-dependent co-stimulation to resist T-cell exhaustion and senescence, sustaining proliferation, cytokine release, cytokine signaling and metabolic fitness upon repeated stimulation. When engineered using targeting moieties of diverse composition, affinity and specificity, pCAR T-cells consistently elicit superior anti-tumor activity both in vitro and in vivo, warranting clinical development.

ORGANISM(S): Homo sapiens

PROVIDER: GSE186557 | GEO | 2021/12/10

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2020-09-18 | GSE158144 | GEO
2018-07-31 | GSE112566 | GEO
2018-07-31 | GSE111641 | GEO
2023-05-02 | GSE231309 | GEO
2023-05-02 | GSE231311 | GEO
2023-05-02 | GSE231310 | GEO
2015-01-14 | E-GEOD-64914 | biostudies-arrayexpress
2020-12-16 | GSE142506 | GEO
2018-08-13 | PXD007921 | Pride
2018-04-20 | GSE113388 | GEO